Zenas BioPharma, Inc. Debt Related Commitment Fees and Debt Issuance Costs
Zenas BioPharma, Inc. (ZBIO) reported Debt Related Commitment Fees and Debt Issuance Costs of $1.75 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts · last filed 2026-08-13
- Zenas BioPharma, Inc. debt related commitment fees and debt issuance costs for the quarter ending 2026-06-30 was $1.75M.
| Period end | Debt Related Commitment Fees and Debt Issuance Costs 3 month | Debt Related Commitment Fees and Debt Issuance Costs 6 month |
|---|---|---|
| 2026-06-30 | $1.75M 10-Q · filed 2026-08-13 | $1.75M 10-Q · filed 2026-08-13 |